Clinical trial
Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages
NCT05445570 is registered in ClinicalTrials.gov with Venn Biosciences Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-invasive Identification of Colorectal Cancer and Adenomas in Early Stages
- Lead sponsor
- Venn Biosciences Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 13, 2022
- Completion date
- March 19, 2024
- Enrollment
- 3,002 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer